Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


SMi ADMET 2014

30 Jun 2014 - 01 Jul 2014 - London, UK



Bookmark and Share


SMi presents the 9th annual conference on: ADMET

Enhancing drug quality by ADMET optimisation in discovery

SMi’s established ADMET conference has been a premier event in its field for almost a decade. The 9th annual event taking place on 30th June and 1st July in central London, will bring together even more industry leading experts to deliver over eighteen case study driven presentations. A focal point for anyone working in the market for drug discovery and development, attending provides a unique forum to engage with KOL’s and experts active in the field.

ADMET 2014 will enable delegates to gain valuable insights into enhancing drug quality by ADMET optimisation in discovery. It will focus on themes including Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes. Click here for the agenda  

 Previous events in the ADMET series have received positive feedback from the industry including, 

"Excellent" – Pharmidex, "Nice mix of attendees" – Grunenthal, "Good conference at general level to update your current knowledge" - Orion Corporation and "Great conference…well organised" - Sanofi

Key Speakers Include:

  • Natalie Gobeau, Metabolism and Pharmacokinetics, Novartis
  • Dietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-Aventis
  • Sarah Baldwin, In Vitro DMPK Manager, GSK
  • Chris Powell, VP Safety Assessment, GSK
  • Georg Schmitt, Head of Toxicology, Roche Pharmaceuticals
  • Richard Thompson, Principal Scientist, AstraZeneca
  • Franck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCB
  • Adina Tocoian, Senior Clinical Pharmacologist, UCB
  • David Fairman, Senior Clinical Pharmacokinetist, MedImmune

Reasons to Attend:

  • Understand how to integrate ADME and toxicity data to enhance the prediction and understanding of drug safety in humans 
  • Hear the latest updates on drug transporters including the evolving transporter strategies in drug development and the different roles of drug transporters in R&D 
  • Explore the ADME properties of peptides in drug discovery 
  • Evaluate and overcome the challenges of making an accurate human dose prediction 

Registration is now live. Click here to secure your place today and save £300.

For further details and to book your place, visit: http://www.smi-online.co.uk/goto/2014admet8.asp

Alternatively contact the Team on +44 (0)20 7827 6000 or email events@smi-online.co.uk 



Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Real-Time Imaging of Embryo Development Could Pave the Way
Researchers at IMCB have developed advanced microscopy technologies to monitor embryo development for more effective human reproduction therapies.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Visual Impairment, Blindness Cases in U.S. Expected to Double by 2050
Researchers at NIH have suggested that there is a need for increased screening and interventions to identify and address treatable causes of vision loss.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!